Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

and viral antigens were detected in alveolar and bronchiolar epithelial cells. Based on these results, the research team argues that the pathology of infected Ob/Ob mice reflects the pathology of ...

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progressesScientists believe ...

Mayo Clinic researchers find that stem cells with the highest Myc expression become dominant in driving lung remodeling .

Researchers reveal how targeting HIF2 could transform the treatment of idiopathic pulmonary fibrosis (IPF), offering hope for ...